Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.800.800.890.940.76

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 0.80 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.80
Mar20240.80
Mar20230.89
Mar20220.94
Mar20210.76

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.8
0.00
Mar2024 0.8
-10.11
Mar2023 0.89
-5.32
Mar2022 0.94
23.68
Mar2021 0.76 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹17,126.7 Cr 2.3% -10.9% 5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

2.3%

-10.9%

5%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses